UK Veterinary Sector Faces Regulatory Overhaul as Watchdog Cracks Down on Fees
The United Kingdom's competition regulator has imposed sweeping new requirements on veterinary practices following a comprehensive investigation that revealed pet owners have been systematically "left in the dark" about treatment costs. The Competition and Markets Authority (CMA) has mandated that written prescription fees be capped at £21 for the first medication and £12.50 for any additional drugs, while simultaneously ordering practices to publish clear price lists and establish a cost comparison website.
Market Investigation Uncovers Widespread Consumer Concerns
After a rigorous two-and-a-half-year examination of the £6.7 billion veterinary market, the CMA concluded that "there is not strong competition between veterinary businesses," with large corporate chains dominating the landscape. The watchdog found that average prices for veterinary services had escalated dramatically, increasing by 63% between 2016 and 2023—a rate substantially exceeding general inflation during the same period.
Martin Coleman, chair of the independent inquiry group, emphasized the significance of these findings: "Too often, people are left in the dark about who owns their practice, treatment options and prices—even when facing bills running into thousands of pounds. Our measures mean it will be made clear to pet owners which practices are part of large groups, which are charging higher prices, and for the first time, vet businesses will be held to account by an independent regulator."
Comprehensive Regulatory Measures Announced
The legally binding requirements extend beyond prescription fee limitations. Veterinary practices must now explicitly inform pet owners that medications may be available at lower prices through online pharmacies and provide written estimates for any treatment expected to cost £500 or more, excluding emergency situations. Additionally, practices must furnish itemized bills to ensure complete transparency.
Large veterinary groups, which collectively control more than 60% of UK practices, will be required to clearly disclose their corporate ownership structures. The six dominant players—CVS, Pets at Home, Medivet, IVC, VetPartners, and Linnaeus—represent a mix of publicly listed companies, private equity-owned enterprises, and subsidiaries of multinational corporations like Mars Petcare.
Industry Response and Implementation Timeline
CVS, one of the largest veterinary groups, expressed satisfaction that the CMA had considered industry feedback regarding the fee cap, noting that the final £21 limit was less severe than the previously proposed £16 restriction. The company stated: "While we continue to believe that some of these remedies are not fully justified, we are comfortable with them and believe they are workable."
Vets for Pets, the 452-practice division of Pets at Home, welcomed the regulatory modernization, stating they looked forward to participating in ongoing discussions about sector reform. The British Veterinary Association president, Rob Williams, acknowledged the positive aspects of increased transparency while noting that "delivering highly skilled veterinary medicine is costly" and price increases reflected broader business cost pressures.
Financial Impact and Consumer Protection
Pet owners collectively spent over £6.7 billion on veterinary and related services in 2024, averaging £390 per pet-owning household. However, individual expenses can be substantially higher, with procedures like canine cruciate ligament surgery sometimes exceeding £5,000. The CMA estimates that its new measures could save consumers hundreds of pounds annually through improved price competition and transparency.
The regulator criticized the existing 60-year-old veterinary governance framework as "outdated," noting that it applied to individual veterinarians but not to corporate practices or businesses, creating regulatory gaps where significant concerns had emerged. The CMA's investigation revealed internal documents from large veterinary groups that explicitly linked price increases to expectations that pet owners would not reduce consumption or switch providers in response.
Pet owners utilizing chain veterinary practices can anticipate visible changes before the Christmas period, including standardized price lists and enhanced disclosure requirements. These reforms represent the most substantial regulatory intervention in the UK veterinary sector in decades, fundamentally reshaping how pricing information is communicated to consumers.
